Bisphosphonates do not delay engraftment after autologous SCT in patients with newly diagnosed myeloma

Bone Marrow Transplant. 2015 Jan;50(1):157. doi: 10.1038/bmt.2014.225. Epub 2014 Oct 13.

Authors

M J Oksman¹, M Itälä-Remes¹, M Kauppila¹, M Putkonen¹, U Salmenniemi¹, T Salmi¹, K Remes¹

Affiliation

¹ Division of Medicine, Department of Hematology and Stem Cell Transplantation, Turku University Hospital, Turku, Finland.

PMID: 25310301
DOI: 10.1038/bmt.2014.225

No abstract available

Publication types

Evaluation Study
Letter

MeSH terms

Autografts
Bone Density Conservation Agents / administration & dosage*
Bone Density Conservation Agents / adverse effects
Diphosphonates / administration & dosage*
Diphosphonates / adverse effects
Female
Graft Survival / drug effects*
Humans
Male
Multiple Myeloma / diagnosis*
Multiple Myeloma / therapy*
Registries*
Retrospective Studies
Stem Cell Transplantation*

Substances

Bone Density Conservation Agents
Diphosphonates